Efficacy of EGFR plus TNF inhibition in a preclinical model of temozolomide-resistant glioblastoma

BACKGROUND: Glioblastoma (GBM) is the most common primary malignant adult brain tumor. Temozolomide (TMZ) is the standard of care and is most effective in GBMs that lack the DNA repair protein O(6)-methylguanine-DNA methyltransferase (MGMT). Moreover, even initially responsive tumors develop a secon...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Autores principales: Guo, Gao, Gong, Ke, Puliyappadamba, Vineshkumar Thidil, Panchani, Nishah, Pan, Edward, Mukherjee, Bipasha, Damanwalla, Ziba, Bharia, Sabrina, Hatanpaa, Kimmo J, Gerber, David E, Mickey, Bruce E, Patel, Toral R, Sarkaria, Jann N, Zhao, Dawen, Burma, Sandeep, Habib, Amyn A
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2019
Materias:
Basic and Translational Investigations
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6917414/
https://ncbi.nlm.nih.gov/pubmed/31363754
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz127
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares